Relay Therapeutics Statistics
Total Valuation
RLAY has a market cap or net worth of $858.84 million. The enterprise value is $158.83 million.
| Market Cap | 858.84M |
| Enterprise Value | 158.83M |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, after market close.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
RLAY has 132.74 million shares outstanding. The number of shares has increased by 7.85% in one year.
| Shares Outstanding | 132.74M |
| Shares Change (YoY) | +7.85% |
| Shares Change (QoQ) | +4.86% |
| Owned by Insiders (%) | 2.14% |
| Owned by Institutions (%) | 101.20% |
| Float | 94.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 24.31 |
| Forward PS | 2,658.92 |
| PB Ratio | 1.15 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.50 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.73, with a Debt / Equity ratio of 0.07.
| Current Ratio | 20.73 |
| Quick Ratio | n/a |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -42.70% and return on invested capital (ROIC) is -46.29%.
| Return on Equity (ROE) | -42.70% |
| Return on Assets (ROA) | -37.00% |
| Return on Capital (ROIC) | -46.29% |
| Revenue Per Employee | $109,372 |
| Profits Per Employee | -$1.02M |
| Employee Count | 323 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.89% in the last 52 weeks. The beta is 1.66, so RLAY's price volatility has been higher than the market average.
| Beta (5Y) | 1.66 |
| 52-Week Price Change | -48.89% |
| 50-Day Moving Average | 6.79 |
| 200-Day Moving Average | 8.33 |
| Relative Strength Index (RSI) | 43.29 |
| Average Volume (20 Days) | 1,609,450 |
Short Selling Information
The latest short interest is 9.85 million, so 7.42% of the outstanding shares have been sold short.
| Short Interest | 9.85M |
| Short Previous Month | 9.60M |
| Short % of Shares Out | 7.42% |
| Short % of Float | 10.43% |
| Short Ratio (days to cover) | 6.98 |
Income Statement
In the last 12 months, RLAY had revenue of $35.33 million and -$329.12 million in losses. Loss per share was -$2.64.
| Revenue | 35.33M |
| Gross Profit | 35.33M |
| Operating Income | -369.44M |
| Pretax Income | -329.12M |
| Net Income | -329.12M |
| EBITDA | -323.65M |
| EBIT | -329.12M |
| Loss Per Share | -$2.64 |
Balance Sheet
The company has $752.32 million in cash and $52.31 million in debt, giving a net cash position of $700.01 million or $5.27 per share.
| Cash & Cash Equivalents | 752.32M |
| Total Debt | 52.31M |
| Net Cash | 700.01M |
| Net Cash Per Share | $5.27 |
| Equity (Book Value) | 745.76M |
| Book Value Per Share | 5.62 |
| Working Capital | 732.96M |
Cash Flow
In the last 12 months, operating cash flow was -$283.51 million and capital expenditures -$3.99 million, giving a free cash flow of -$287.50 million.
| Operating Cash Flow | -283.51M |
| Capital Expenditures | -3.99M |
| Free Cash Flow | -287.50M |
| FCF Per Share | -$2.20 |
Margins
Gross margin is 100.00%, with operating and profit margins of -1,045.76% and -931.64%.
| Gross Margin | 100.00% |
| Operating Margin | -1,045.76% |
| Pretax Margin | -931.64% |
| Profit Margin | -931.64% |
| EBITDA Margin | -916.17% |
| EBIT Margin | -931.64% |
| FCF Margin | -813.83% |
Dividends & Yields
RLAY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.85% |
| Shareholder Yield | -7.85% |
| Earnings Yield | -38.32% |
| FCF Yield | -33.48% |
Analyst Forecast
The average price target for RLAY is $22.80, which is 252.40% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $22.80 |
| Price Target Difference | 252.40% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 40.91% |
| EPS Growth Forecast (5Y) | -7.42% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RLAY has an Altman Z-Score of 2.72 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.72 |
| Piotroski F-Score | 4 |